A group of pharmaceutical companies, including Allergan (NYSE:AGN) and Merck (NYSE:MRK), have asked the Supreme Court to review a case between the industry players and patients regarding the design of the companies’ eye-droppers, according to a report from the AP.
In the on-going legal debate, patient groups have claimed that the companies’ devices dispense large drops of medication that overwhelm the eye and ultimately waste expensive drug product. The users also allege that if the bottle was properly designed to dispense smaller drops of medicine, they would pay less.
Registration is open for DeviceTalks Boston! Join us on June 5-6, 2019, as we explore the trends and technology that are shaping the future of the medical device industry.